Antenatal Betamethasone Compared to Dexamethasone - "BETACODE TRIAL"
Completed
Antenatal corticosteroids result in substantial decrease in neonatal morbidity and mortality by specifically reducing the risk of respiratory distress syndrome, intraventricular hemorrhage and neonatal death among premature infants. No human randomized study has formally compared betamethasone and dexamethasone, the preferred corticosteroids for antenatal therapy, with regards to their effectiveness in reducing neonatal morbidities and mortality. Our objective was to compare betamethasone with d... Read More
Gender:
FEMALE
Ages:
Between 18 years and 45 years
Trial Updated:
01/02/2007
Locations: Stony Brook University Hospital, Stony Brook, New York
Conditions: Respiratory Distress Syndrome, Intraventricular Hemorrhage, Neonatal Mortality